- Company Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Biohaven Pharmaceutical Holding 8-K28 Feb 20Biohaven’s Nurtec™ Odt (Rimegepant) Receives Fda Approval for the Acute Treatment of Migraine In AdultsFinancial data
Company Profile